$JNJ Recent Headlines Feds, pharma rivals team up on

New Post Public Reply Private Reply Replies (0) Message Board

Feb 7, 2014 at 10:11 AM

$JNJ Recent Headlines

Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson sees 2014 EPS of $5.75 to $5.85 7:51 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS excluding items $1.24 7:50 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 sales up 4.5% to $18.4B 7:49 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS $1.23 vs. 91 cents 7:48 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Verizon, Delta, IBM are stocks to watch Tuesday 6:28 a.m. Jan. 21, 2014 - Sue Chang
‘Sloppy’ market turns to consumer, tech earnings 8:00 a.m. Jan. 19, 2014 - Wallace Witkowski
Carlyle buying J&J diagnostics unit for $4.15 bln 8:17 a.m. Jan. 16, 2014 - William L. Watts
Carlyle offers $4.15 bln for J&J diagnostics unit 8:04 a.m. Jan. 16, 2014 - William L. Watts
Pharmacyclics shares soar after panel says cancer drug met goals 12:09 p.m. Jan. 7, 2014 - blogs.marketwatch.com

Carlyle to Buy Illinois Tool Unit for $3.2 Billion 7:07 p.m. Feb. 6, 2014 - WSJ.com
Johnson & Johnson (JNJ): Today's Featured Drugs Winner 5:00 p.m. Feb. 6, 2014 - TheStreet.com
Interesting JNJ Put And Call Options For March 14th 11:01 a.m. Feb. 6, 2014 - TheStreet.com
February High Yield Dividend Champion 5:34 a.m. Feb. 6, 2014 - Seeking Alpha
DXCM: Improving the Quality of Life for Children With Diabetes 8:38 p.m. Feb. 5, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Pullback In Stock Prices Makes These Dividend Payers Attractive Again 6:51 p.m. Feb. 5, 2014 - Seeking Alpha
Stocks Tend to Outperform Bonds but with Greater Risk 5:08 p.m. Feb. 5, 2014 - GuruFocus.com
Smith & Nephew Becomes Pharma Family Factor 6:30 a.m. Feb. 5, 2014 - TheStreet.com
AstraZeneca's Prescription for Growth 6:00 a.m. Feb. 5, 2014 - TheStreet.com
Gilead Beats Q4 Estimates, But Ducks Sovaldi Guidance 5:51 p.m. Feb. 4, 2014 - Investors Business Daily
My First Equity Investment Since 2012 9:57 a.m. Feb. 4, 2014 - GuruFocus.com
Is Anyone Really Surprised By The Recent Stock Market Sell-Off?! 9:12 a.m. Feb. 4, 2014 - Seeking Alpha
Merrill Lynch’s Top Dividend and Yield Stocks to Buy During the Pullback 8:36 a.m. Feb. 4, 2014 - 247WallSt.com
Big Pharma firms, NIH to join up to study major diseases 8:28 a.m. Feb. 4, 2014 - Seeking Alpha
Today's Market: What We Are Buying And Looking To Buy On This Pullback 8:13 a.m. Feb. 4, 2014 - Seeking Alpha
Merck's Future Looks Healthier 6:00 a.m. Feb. 4, 2014 - TheStreet.com
2 Steps To A Solid And Profitable Portfolio 5:34 a.m. Feb. 4, 2014 - Seeking Alpha
Rival Companies, NIH Form Pact in Search for New Drugs 11:04 p.m. Feb. 3, 2014 - WSJ.com
Why I Am Buying Philip Morris International 8:16 a.m. Feb. 3, 2014 - GuruFocus.com

United Kingdom Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 1:10 p.m. Feb. 5, 2014 - PR Newswire - PRF
Sustainable Brands® Community Continues to Lead With Brand Innovation Conference 9:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Girard Gibbs LLP Represents Children Allegedly Injured by Risperdal 7:40 p.m. Feb. 4, 2014 - BusinessWire - BZX
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting 10:38 a.m. Feb. 3, 2014 - ACCESSWIRE
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India 9:58 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call for Nominations 9:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine 12:01 a.m. Jan. 30, 2014 - PR Newswire - PRF
Risperdal Lawsuit News: Johnson & Johnson Wins Appeal of $257 Million Louisiana Risperdal Verdict, Bernstein Liebhard LLP Reports 11:21 a.m. Jan. 29, 2014 - PR Newswire - PRF
PowerVision Closes $20MM in Its Series D Financing 4:15 p.m. Jan. 28, 2014 - PR Newswire - PRF
Two-Year Data from INNOVATION Trial on INCRAFT® AAA Stent Graft System Continues to Demonstrate Safety and Performance in Treatment of Abdominal Aortic Aneurysms 9:00 a.m. Jan. 28, 2014 - BusinessWire - BZX
Acclarent Launches a Complete Balloon Sinuplasty System for Children who Suffer From Chronic Sinusitis 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
DePuy ASR Lawsuit News: DePuy ASR Hip Recall Continues to Impact Johnson & Johnson Earnings, Bernstein Liebhard LLP Reports 11:28 a.m. Jan. 22, 2014 - PR Newswire - PRF
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
Janssen Announces New Group Targeting Unmet Global Health Needs 8:15 a.m. Jan. 22, 2014 - PR Newswire - PRF
Three-Year Clinical Outcomes from STROLL Trial Demonstrate Sustained Durability and Performance of S.M.A.R.T.® Stent for Treatment of Peripheral Artery Disease 5:56 p.m. Jan. 21, 2014 - BusinessWire - BZX
MD Anderson Announces Collaboration With Johnson & Johnson Innovation On Cancer Immunotherapy 12:38 p.m. Jan. 21, 2014 - PR Newswire - PRF
Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results: 7:45 a.m. Jan. 21, 2014 - PR Newswire - PRF
Fitch: JNJ's Diagnostics Divestiture Makes Strategic Sense 8:47 a.m. Jan. 17, 2014 - BusinessWire - BZX
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics 7:45 a.m. Jan. 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ALMIA's Bold Medicare Defense to HHS Committee

ALMIA Lays It Out for Medicare Stakeholders The folks at ALMIA are shaking things up, and they're not pulling any punches with the HHS Healthcare Advisory Committee. With this latest move, they've lobbed public comments towards the committee, especially ahead of this intense November 9th meeting. It's part of a larger dialogue kicked off with the Strengthening Medicare...

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Datavault AI's Turbulent Boardroom Saga Escalates

The Corporate Chess Game at Datavault AI If there's one thing Wall Street hates, it's uncertainty. And boy, does Datavault AI (NASDAQ: DVLT) deliver plenty of it right now. Founder Nathaniel Bradley has lobbed a lawsuit at the board, claiming that Chairman and CFO Brett Moyer orchestrated a coup to oust him without proper board procedures. Talk about drama fit for a soap...

Cognizant Grabs Wizeline: A Power Play in Digital

An Acquisition with Strategic Weight Cognizant's just bagged a beast, folks. The purchase of Wizeline marks a hefty step for NASDAQ:CTSH in the ever-evolving landscape of digital engineering and AI. It's not the kind of strategic move you see every day. The Wizeline Asset: What Stands Out? Wizeline isn't just window dressing. It's a heavy hitter in AI-native digital...

Encore Boston Harbor Workers Triumph After 62-Day Strike

Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...

JOYEE N01 Kicks Off Global Launch with African Orders

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Beverly Hills Body Academy: A New Era in Contouring

Setting New Standards in Body Contouring It's no secret that Beverly Hills is all about luxury and cutting-edge trends. So, when the Beverly Hills Body Academy™ (BHBA) sets up shop in this glitzy locale, it's a pretty loud statement in the world of body contouring. This isn't just another vanity-driven operation; it's about pioneering advancements in the field of body...

NextPlat Gears Up for Q3 2026 Earnings Call

NextPlat's Upcoming Financial Revelation November is shaping up to be a month of revelations for NextPlat Corp (NASDAQ:NXPL) as they prepare to spill the beans on their third-quarter 2026 financials. The number crunching wraps up at 8:30 a.m. Eastern on November 12, when the execs will host an investor conference call. The Details of the Big Day Coming to you live from...

CleanSpark Sets Investor Events with Promising Outlook

CleanSpark's Strategy Gets the Spotlight Looks like CleanSpark's stepping up to the plate, folks. They're shouting from the rooftops about hitting the upcoming investor events, and it’s no small potatoes. The company’s lined up a string of high-profile conferences, showcasing their ambition to stay ahead in the energy and data center games. We're talking about the...

Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...